Meanwhile, the value of five pharmaceutical companies fell in 2017 as Merck & Co, Celgene, GlaxoSmithKline (GSK), Allergan and Shire all saw their market capitalisation decline.
Payouts to shareholders of large publicly traded health companies more than tripled over the past two decades, new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback